冠心病患者脂蛋白脂肪酶多态性的分布分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The Distribution of Lipoprotein. Lipase Gene Polymorphisms in Patient with Coronary Hear Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    为了探讨脂蛋白脂肪酶基因内含子6区(PvuⅡ)和8区(HindⅢ)位点变异与冠心病的关系,应用聚合酶链反应一限制性片段长度多态性方法分析106例心肌梗塞存活病人及106例正常健康人的脂蛋白脂肪酶基因PvuⅡ、HindⅢ位点多态性。并采用非条件的lo-gistic单元及多元回归分析。结果发现,糖尿病史、吸烟史、高血压、脂蛋白脂肪酶等位基因P-和单倍体H+P-是冠心病独立的危险因素,其中P-和H+P-在多元回归分析后其比值比为3.59和2.54,载脂蛋白A/B的比值比为0.06。因此认为除传统的危险因素外,脂蛋白脂肪酶P-和单倍体H+P-也是冠心病独立的危险因素,载脂蛋白A/B比值可能是较其他血脂指标更好的冠心病独立的预测危险因素。

    Abstract:

    Aim Whether the mutation of lipoprotein lipase (LPL) gene is associated with coronary heart disease (CHD) or not has been yet knon We study rela-tionship between mutation in intro 6(PvuⅡ) and 8region of LPL gene and CHDMethods We analysed 106 patients in myocardial infarction survivors through a case-control study.The technique of lpoymerase chain reaction (PCR)-re-striction fragment lengths polymorphism(RFLP)was useh to analysed the genotype of LPL gene.23 fac-tors maybe involved in CHD was chosed. Simple and multiple non-conditioned logistic regression analysis demostrated that 6factors were association with CHD.Results The risk factors were diabetes, smoke,hypertension,LPL GENOTYPE pvu ⅡP P and haplo-type H+ P-. While Apo A/B ratio was regarded as a protective factor.Conclusion LPL genotype Pvu P-P- or H+P- oth-er than the standard risks was contribuing to CHD.

    参考文献
    相似文献
    引证文献
引用本文

朱铁兵,王海燕,王强,钱卫冲,王连生.冠心病患者脂蛋白脂肪酶多态性的分布分析[J].中国动脉硬化杂志,1998,6(3):215~218.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:1998-05-31
  • 最后修改日期:1998-08-18
  • 录用日期:
  • 在线发布日期: